Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.23.2
Segment Information (Details)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jun. 30, 2023
USD ($)
segment
Jun. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
Segment Reporting [Abstract]                  
Number of operating segments | segment             3    
Segment Reporting Information [Line Items]                  
Consolidated Sales $ 471,908     $ 421,719     $ 1,400,728 $ 1,305,276  
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]                  
Total Adjusted EBITDA 56,188     46,024     163,926 154,547  
Non-Operating Income and Expenses [Abstract]                  
Acquisition and divestiture costs (308)     (951)     (4,445) (951)  
Strategic initiatives and other charges (4,694)     (6,339)     (7,734) (16,912)  
Non-recurring / incremental coronavirus disease 2019 ("COVID-19") costs 0     (301)     0 (2,204)  
Highly inflationary accounting losses (primarily non-cash) (1,826)     0     (3,074) 0  
Defined benefit plan termination related items 0     63     (21) (284)  
Asset write-downs 0     469     0 (10,017) $ (10,017)
Stock-based compensation (5,023)     (5,197)     (13,635) (14,128)  
Non-service pension and postretirement expense (85)     (238)     (1,556) (31,588)  
Depreciation and amortization (23,936)     (22,938)     (71,813) (80,163)  
Interest expense, including RPA and factoring financing fees (12,136)     (6,659)     (35,944) (19,426)  
Net loss attributable to noncontrolling interests (67)     (18)     (125) (56)  
Income (loss) before income taxes 8,113     3,915     25,579 (21,182)  
Income tax benefit (provision) 558     (1,040)     (4,136) 2,311  
Net income (loss) 8,671 $ 9,125 $ 3,647 2,875 $ (1,936) $ (19,810) 21,443 (18,871)  
Loss recovery             2,154    
RPA and factoring financing fees (1,212)           (2,758)    
Memorialization                  
Segment Reporting Information [Line Items]                  
Consolidated Sales 208,728     203,158     638,119 633,868  
Industrial Technologies                  
Segment Reporting Information [Line Items]                  
Consolidated Sales 130,533     78,443     365,190 230,928  
SGK Brand Solutions                  
Segment Reporting Information [Line Items]                  
Consolidated Sales 132,647     140,118     397,419 440,480  
Operating Segments | Memorialization                  
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]                  
Total Adjusted EBITDA 39,929     32,090     127,096 118,404  
Non-Operating Income and Expenses [Abstract]                  
Non-recurring / incremental coronavirus disease 2019 ("COVID-19") costs       (225)       (1,268)  
Depreciation and amortization (5,807)     (5,835)     (17,092) (17,448)  
Acquisition costs, ERP integration costs, and strategic initiatives and other charges 270     902     981 2,090  
Operating Segments | Industrial Technologies                  
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]                  
Total Adjusted EBITDA 15,041     11,809     42,808 33,377  
Non-Operating Income and Expenses [Abstract]                  
Non-recurring / incremental coronavirus disease 2019 ("COVID-19") costs       (1)       (6)  
Depreciation and amortization (5,815)     (2,459)     (17,584) (7,643)  
Acquisition costs, ERP integration costs, and strategic initiatives and other charges 120     1,183     3,494 1,376  
Operating Segments | SGK Brand Solutions                  
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]                  
Total Adjusted EBITDA 16,364     14,546     39,616 43,422  
Operating Segments | Brand Solutions                  
Non-Operating Income and Expenses [Abstract]                  
Non-recurring / incremental coronavirus disease 2019 ("COVID-19") costs       (74)       (464)  
Depreciation and amortization (11,164)     (13,334)     (33,543) (51,119)  
Acquisition costs, ERP integration costs, and strategic initiatives and other charges 3,897     1,970     7,028 7,673  
Corporate and Non-Operating                  
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]                  
Total Adjusted EBITDA (15,146)     (12,421)     (45,594) (40,656)  
Non-Operating Income and Expenses [Abstract]                  
Non-recurring / incremental coronavirus disease 2019 ("COVID-19") costs       (1)       (466)  
Depreciation and amortization (1,150)     (1,310)     (3,594) (3,953)  
Acquisition costs, ERP integration costs, and strategic initiatives and other charges $ 715     $ 3,235     $ 676 $ 6,724